MGP and osteoporosis: These findings and the recent failure of denosumab and alendronic acid, both effectors of bone turnover and used to treat osteoporosis, to slow valvular calcification25, suggest that the effect of vitamin K and the Matrix Gla Protein pathway on the progression of valvular and coronary artery calcification appear more complex and might not be the key clinical drivers.